AAAAAA

   
Results: 1-11 |
Results: 11
In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia
Authors: Ramakers-van Woerden, NL Pieters, R Slater, RM Loonen, AH Beverloo, HB van Drunen, E Heyman, M Moreno, TC Rots, MG van Wering, ER Kamps, WA Janka-Schaub, GE Veerman, AJP
Citation: Nl. Ramakers-van Woerden et al., In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia, BR J HAEM, 112(3), 2001, pp. 680-690
Long-term results of large prospective trials in childhood acute lymphoblastic leukemia
Authors: Schrappe, M Camitta, B Pui, CH Eden, T Gaynon, P Gustafsson, G Janka-Schaub, GE Kamps, W Masera, G Sallan, S Tsuchida, M Vilmer, E
Citation: M. Schrappe et al., Long-term results of large prospective trials in childhood acute lymphoblastic leukemia, LEUKEMIA, 14(12), 2000, pp. 2193-2194
Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92
Authors: Harms, DO Janka-Schaub, GE
Citation: Do. Harms et Ge. Janka-schaub, Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92, LEUKEMIA, 14(12), 2000, pp. 2234-2239
Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia
Authors: Rots, MG Pieters, R Peters, GJ Noordhuis, P Van Zantwijk, CH Henze, G Janka-Schaub, GE Veerman, AJP Jansen, G
Citation: Mg. Rots et al., Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia, BR J HAEM, 109(3), 2000, pp. 629-634
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia
Authors: Zwaan, CM Kaspers, GJL Pieters, R Ramakers-Van Woerden, NL den Boer, ML Wunsche, R Rottier, MMA Hahlen, K van Wering, ER Janka-Schaub, GE Creutzig, U Veerman, AJP
Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2779-2786
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia
Authors: Zwaan, CM Kaspers, GJL Pieters, R Woerden, NLR den Boer, ML Wunsche, R Rottier, MMA Hahlen, K van Wering, ER Janka-Schaub, GE Creutzig, U Veerman, AJP
Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2879-2886
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia
Authors: Ramakers-van Woerden, NL Pieters, R Loonen, AH Hubeek, I van Drunen, E Beverloo, HB Slater, RM Harbott, J Seyfarth, J van Wering, ER Hahlen, K Schmiegelow, K Janka-Schaub, GE Veerman, AJP
Citation: Nl. Ramakers-van Woerden et al., TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia, BLOOD, 96(3), 2000, pp. 1094-1099
Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia
Authors: Den Boer, ML Pieters, R Kazemier, KM Janka-Schaub, GE Henze, G Veerman, AJP
Citation: Ml. Den Boer et al., Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia, LEUKEMIA, 13(12), 1999, pp. 2023-2030
In vitro drug resistance as independent prognostic factor in study COALL-05-92 for treatment of childhood acute lymphoblastic leukemia: Basis for treatment stratification according to traditional risk factors and drug sensitivity in study COALL-06-97
Authors: Janka-Schaub, GE Harms, DO den Boer, ML Veerman, AJP Pieters, R
Citation: Ge. Janka-schaub et al., In vitro drug resistance as independent prognostic factor in study COALL-05-92 for treatment of childhood acute lymphoblastic leukemia: Basis for treatment stratification according to traditional risk factors and drug sensitivity in study COALL-06-97, KLIN PADIAT, 211(4), 1999, pp. 233-238
Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance
Authors: Den Boer, ML Kapaun, P Pieters, R Kazemier, KM Janka-Schaub, GE Veerman, AJP
Citation: Ml. Den Boer et al., Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance, BR J HAEM, 105(4), 1999, pp. 876-882
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia
Authors: Den Boer, ML Pieters, R Kazemier, KM Janka-Schaub, GE Henze, G Creutzig, U Kaspers, GJL Kearns, PR Hall, AG Pearson, ADJ Veerman, AJP
Citation: Ml. Den Boer et al., Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia, BR J HAEM, 104(2), 1999, pp. 321-327
Risultati: 1-11 |